(Q44079966)

29 November 2017

title

Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients (English)

1 reference

29 November 2017

0 references

David Axelrod

1

0 references

Dixon B Kaufman

series ordinal

5

object named as

Dixon B Kaufman

1 reference

29 November 2017

Joseph R Leventhal

2

1 reference

29 November 2017

Lorenzo G Gallon

series ordinal

3

1 reference

29 November 2017

Michele A Parker

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

American Journal of Transplantation

29 November 2017

published in

1 reference

29 November 2017

volume

5

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

1423-1429

1 reference

Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

The impact of simultaneous pancreas-kidney transplantation on long-term patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Lessons learned from more than 1,000 pancreas transplants at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00855.X

10.1111/J.1600-6143.2005.00855.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference